Neuberger Berman Group
CVS icon

Neuberger Berman Group’s CVS Health CVS Stock Holding History

Neuberger Berman Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.4M Buy
645,884
+304,865
+89% +$23.5M 0.04% 489
2025
Q4 		$27.1M Buy
341,019
+20,888
+7% +$1.65M 0.02% 597
2025
Q3 		$24.1M Sell
320,131
-182,630
-36% -$12.5M 0.02% 620
2025
Q2 		$34.7M Buy
502,761
+155,252
+45% +$10.2M 0.03% 520
2025
Q1 		$23.5M Sell
347,509
-31,366
-8% -$1.88M 0.02% 586
2024
Q4 		$17M Buy
378,875
+35,436
+10% +$1.99M 0.01% 701
2024
Q3 		$21.6M Sell
343,439
-21,544
-6% -$1.26M 0.02% 645
2024
Q2 		$21.6M Sell
364,983
-2,309,879
-86% -$144M 0.02% 618
2024
Q1 		$213M Sell
2,674,862
-16,321
-0.6% -$1.25M 0.18% 149
2023
Q4 		$212M Buy
2,691,183
+2,370,507
+739% +$169M 0.19% 147
2023
Q3 		$22.4M Sell
320,676
-29,578
-8% -$2.1M 0.02% 579
2023
Q2 		$24.2M Sell
350,254
-141,092
-29% -$10M 0.02% 566
2023
Q1 		$36.5M Sell
491,346
-1,192,844
-71% -$100M 0.03% 488
2022
Q4 		$157M Sell
1,684,190
-20,823
-1% -$2.01M 0.15% 183
2022
Q3 		$163M Buy
1,705,013
+113,055
+7% +$11.2M 0.17% 173
2022
Q2 		$148M Sell
1,591,958
-145,701
-8% -$14.2M 0.15% 194
2022
Q1 		$176M Buy
1,737,659
+41,860
+2% +$4.4M 0.15% 196
2021
Q4 		$173M Buy
1,695,799
+651,407
+62% +$60.2M 0.14% 219
2021
Q3 		$87.9M Sell
1,044,392
-40,680
-4% -$3.41M 0.08% 335
2021
Q2 		$90M Buy
1,085,072
+183,215
+20% +$15M 0.08% 328
2021
Q1 		$67.6M Sell
901,857
-26,219
-3% -$1.91M 0.06% 373
2020
Q4 		$63.3M Sell
928,076
-7,835
-0.8% -$510K 0.07% 353
2020
Q3 		$54.6M Buy
935,911
+365,798
+64% +$22.8M 0.06% 352
2020
Q2 		$37M Buy
570,113
+134,485
+31% +$8.47M 0.05% 417
2020
Q1 		$25.8M Sell
435,628
-2,110,531
-83% -$141M 0.04% 451
2019
Q4 		$189M Sell
2,546,159
-381,395
-13% -$26.8M 0.22% 125
2019
Q3 		$185M Buy
2,927,554
+117,799
+4% +$6.98M 0.23% 119
2019
Q2 		$153M Sell
2,809,755
-4,073,670
-59% -$219M 0.18% 154
2019
Q1 		$371M Buy
6,883,425
+1,788,389
+35% +$110M 0.45% 39
2018
Q4 		$334M Buy
5,095,036
+1,332,499
+35% +$99.5M 0.47% 35
2018
Q3 		$296M Buy
3,762,537
+618,286
+20% +$44.2M 0.34% 62
2018
Q2 		$202M Buy
3,144,251
+299,205
+11% +$19.7M 0.22% 127
2018
Q1 		$177M Sell
2,845,046
-83,023
-3% -$5.96M 0.2% 148
2017
Q4 		$212M Buy
2,928,069
+331,666
+13% +$24.1M 0.24% 122
2017
Q3 		$211M Sell
2,596,403
-199,769
-7% -$15.8M 0.26% 111
2017
Q2 		$225M Sell
2,796,172
-199,168
-7% -$15.7M 0.29% 86
2017
Q1 		$235M Buy
2,995,340
+528,848
+21% +$42.2M 0.3% 76
2016
Q4 		$195M Sell
2,466,492
-847,712
-26% -$68.6M 0.26% 108
2016
Q3 		$295M Sell
3,314,204
-1,477,968
-31% -$140M 0.4% 50
2016
Q2 		$459M Sell
4,792,172
-160,039
-3% -$15.9M 0.63% 16
2016
Q1 		$514M Sell
4,952,211
-490,088
-9% -$47.7M 0.71% 10
2015
Q4 		$532M Buy
5,442,299
+1,588,709
+41% +$156M 0.7% 11
2015
Q3 		$372M Buy
3,853,590
+852,433
+28% +$89.6M 0.48% 37
2015
Q2 		$315M Buy
3,001,157
+564,983
+23% +$57.7M 0.35% 66
2015
Q1 		$251M Buy
2,436,174
+1,208,705
+98% +$122M 0.27% 95
2014
Q4 		$118M Sell
1,227,469
-337,016
-22% -$29.7M 0.12% 233
2014
Q3 		$125M Sell
1,564,485
-414,913
-21% -$32.7M 0.13% 224
2014
Q2 		$149M Sell
1,979,398
-115,335
-6% -$8.72M 0.15% 200
2014
Q1 		$157M Sell
2,094,733
-167,550
-7% -$11.8M 0.16% 187
2013
Q4 		$162M Sell
2,262,283
-78,022
-3% -$5.01M 0.17% 187
2013
Q3 		$133M Sell
2,340,305
-190,594
-8% -$11.4M 0.15% 206
2013
Q2 		$145M Buy
+2,530,899
New +$147M 0.17% 181

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group's CVS Position: Q1 2026 in Review

Neuberger Berman Group increased its CVS Health (CVS) stake by 89% in Q1 2026, buying an estimated $23.5M and bringing the position to 645,884 shares worth $46.4M. The position accounts for 0.04% of the portfolio, ranked #489.

Neuberger Berman Group first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $532M in Q4 2015. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Neuberger Berman Group held 645,884 shares of CVS Health worth $46.4M as of Q1 2026.
  • Neuberger Berman Group bought 304,865 CVS Health shares in Q1 2026, an estimated $23.5M.
  • CVS Health made up 0.04% of Neuberger Berman Group's portfolio in Q1 2026, its #489 holding.
  • Neuberger Berman Group first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Neuberger Berman Group's CVS Health position peaked at $532M in Q4 2015.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.